AU529307B2 - Benzodiazepin adjuvants - Google Patents

Benzodiazepin adjuvants

Info

Publication number
AU529307B2
AU529307B2 AU76517/81A AU7651781A AU529307B2 AU 529307 B2 AU529307 B2 AU 529307B2 AU 76517/81 A AU76517/81 A AU 76517/81A AU 7651781 A AU7651781 A AU 7651781A AU 529307 B2 AU529307 B2 AU 529307B2
Authority
AU
Australia
Prior art keywords
benzodiazepin
adjuvants
benzodiazepin adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU76517/81A
Other languages
English (en)
Other versions
AU7651781A (en
Inventor
Billie Kenneth Koe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of AU7651781A publication Critical patent/AU7651781A/en
Application granted granted Critical
Publication of AU529307B2 publication Critical patent/AU529307B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76517/81A 1980-10-17 1981-10-16 Benzodiazepin adjuvants Ceased AU529307B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US197872 1980-10-17
US06/197,872 US4320124A (en) 1980-10-17 1980-10-17 Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof

Publications (2)

Publication Number Publication Date
AU7651781A AU7651781A (en) 1982-04-22
AU529307B2 true AU529307B2 (en) 1983-06-02

Family

ID=22731077

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76517/81A Ceased AU529307B2 (en) 1980-10-17 1981-10-16 Benzodiazepin adjuvants

Country Status (10)

Country Link
US (1) US4320124A (enExample)
EP (1) EP0050487B1 (enExample)
JP (1) JPS5795912A (enExample)
KR (1) KR830007074A (enExample)
AU (1) AU529307B2 (enExample)
DE (1) DE3166349D1 (enExample)
GR (1) GR75097B (enExample)
IL (1) IL64062A0 (enExample)
NZ (1) NZ198657A (enExample)
PT (1) PT73746B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
US6031098A (en) * 1997-08-11 2000-02-29 California Institute Of Technology Detection and treatment of duplex polynucleotide damage
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
WO2006060736A2 (en) * 2004-12-03 2006-06-08 The Children's Hospital Of Philadelphia A composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
SI1838716T1 (sl) * 2005-01-05 2011-10-28 Lilly Co Eli Olanzapin pamoat dihidrat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
BE854655A (fr) * 1976-05-17 1977-11-16 Pfizer 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents

Also Published As

Publication number Publication date
GR75097B (enExample) 1984-07-13
KR830007074A (ko) 1983-10-14
DE3166349D1 (en) 1984-10-31
JPS5795912A (en) 1982-06-15
PT73746A (en) 1981-10-01
AU7651781A (en) 1982-04-22
EP0050487A1 (en) 1982-04-28
NZ198657A (en) 1985-05-31
IL64062A0 (en) 1982-01-31
EP0050487B1 (en) 1984-09-26
PT73746B (en) 1983-11-08
US4320124A (en) 1982-03-16

Similar Documents

Publication Publication Date Title
AU544099B2 (en) Triazolylpentenols
AU537992B2 (en) Polusilanes
AU541995B2 (en) m
AU545667B2 (en) Diamino-pyridines
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU539188B2 (en) Skin-packaging
AU536754B2 (en) Imidodisulfamides
AU3206284A (en) 2-guanidno-4-heteroarylthiazoles
AU6856581A (en) Metal-amine-carboxylates
AU7395881A (en) Cloches
AU527275B2 (en) Auto-diaphragm hemodialyser
AU537824B2 (en) Oxygensensor
AU7139981A (en) N6-carboxylalkyladenosines
AU7322081A (en) Solaranlage
AU6980181A (en) Bob-sled
AU7475081A (en) 5-amino-tetrazoles
AU529307B2 (en) Benzodiazepin adjuvants
AU539565B2 (en) If amilifier
AU534814B2 (en) Showstand
AU537073B2 (en) Haloacetanilide
AU538427B2 (en) Dichlorobenzoyl-3-phenylpyrazolines
AU517843B2 (en) Guanylamidines
AU548141B2 (en) 1-phenyl-2-triazolyl-pent-gen-3-ols
AU540683B2 (en) Photocomposer
AU525004B2 (en) Phthalimidoguanidines